Eloxx Pharmaceuticals Inc – Filings and Transcripts – BamSEC

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

SEC EDGAR

Financials Filter

Late annual filing notification for FY 2023

ended 09/30/23 Q3

ended 06/30/23 Q2

ended 03/31/23 Q1

ended 12/31/22 FY 2022

Prospectuses and Registrations Filter

Removal from listing

Shelf registration

Registration of securities for employees

Prospectus supplement for primary offering

Prospectus supplement for primary offering

Ownership Filter

Walts Alan Edmund

Androski Lindsay

Roche Finance Ltd

News Filter

Change in Directors, Officers or Compensation

Material Definitive Agreement

Material Definitive Agreement, Unregistered Sales of Equity Securities

Change in Directors, Officers or Compensation, Financial Statements or Exhibits

Material Definitive Agreement, New Financial Obligation or Off-Balance Sheet Arrangement

Proxies Filter

Additional info about upcoming vote

Definitive proxy

Definitive proxy

Preliminary proxy

Additional info about upcoming vote

Other Filter

Confidential treatment order

Notice of effectiveness

Correspondence with the SEC

Letter from the SEC

Notice of effectiveness